WO2024246559 - BICYCLIC HETEROARYLAMIDES HAVING GPR68 MODULATING ACTIVITY
National phase entry is expected:
Publication Number
WO/2024/246559
Publication Date
05.12.2024
International Application No.
PCT/GB2024/051431
International Filing Date
31.05.2024
Title **
[English]
BICYCLIC HETEROARYLAMIDES HAVING GPR68 MODULATING ACTIVITY
[French]
HÉTÉROARYLAMIDES BICYCLIQUES AYANT UNE ACTIVITÉ DE MODULATION DE GPR68
Applicants **
RECURSION PHARMACEUTICALS, INC.
Inventors
RICHARDS, Simon
PRIME, Michael
PAPACHRISTOS, Konstantinos
NAIK, Manisha
OLSEN, Reid Hans Johnson
Priority Data
20230100442
01.06.2023
GR
20240100072
05.02.2024
GR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 11862 | |
| EPO | Filing, Examination, Granting | 36796 | |
| Japan | Filing, Examination, Granting | 2524 | |
| South Korea | Filing, Examination, Granting | 2851 | |
| USA | Filing, Examination, Granting | 10940 |
Total:
64,973
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed are novel GPR68 modulators according to Formula (I), their pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also disclosed are methods of using such compounds and compositions to treat various diseases including cancer and proliferative diseases and disorders.[French]
L'invention concerne de nouveaux modulateurs de GPR68 selon la formule (I), leurs sels pharmaceutiquement acceptables, et des compositions pharmaceutiques de ceux-ci. L'invention concerne également des procédés d'utilisation de tels composés et compositions pour traiter diverses maladies, notamment le cancer et des maladies et troubles prolifératifs.